Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA PANACEA BIOTECH ABBOTT INDIA/
PANACEA BIOTECH
 
P/E (TTM) x 48.7 0.8 6,442.8% View Chart
P/BV x 15.5 1.0 1,513.5% View Chart
Dividend Yield % 1.4 0.0 -  

Financials

 ABBOTT INDIA   PANACEA BIOTECH
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-22
PANACEA BIOTECH
Mar-22
ABBOTT INDIA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs23,902454 5,268.3%   
Low Rs14,553148 9,833.0%   
Sales per share (Unadj.) Rs2,315.0108.0 2,144.3%  
Earnings per share (Unadj.) Rs375.9176.0 213.6%  
Cash flow per share (Unadj.) Rs407.0183.1 222.2%  
Dividends per share (Unadj.) Rs275.000-  
Avg Dividend yield %1.40-  
Book value per share (Unadj.) Rs1,306.2138.6 942.6%  
Shares outstanding (eoy) m21.2561.25 34.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x8.32.8 298.0%   
Avg P/E ratio x51.21.7 2,992.3%  
P/CF ratio (eoy) x47.21.6 2,875.5%  
Price / Book Value ratio x14.72.2 678.0%  
Dividend payout %73.20-   
Avg Mkt Cap Rs m408,57318,427 2,217.2%   
No. of employees `000NANA-   
Total wages/salary Rs m5,7951,829 316.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m49,1936,612 744.0%  
Other income Rs m774110 705.6%   
Total revenues Rs m49,9676,722 743.3%   
Gross profit Rs m10,87516,623 65.4%  
Depreciation Rs m661437 151.4%   
Interest Rs m1911,808 10.6%   
Profit before tax Rs m10,79714,488 74.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,8103,709 75.8%   
Profit after tax Rs m7,98710,779 74.1%  
Gross profit margin %22.1251.4 8.8%  
Effective tax rate %26.025.6 101.7%   
Net profit margin %16.2163.0 10.0%  
BALANCE SHEET DATA
Current assets Rs m38,53010,406 370.3%   
Current liabilities Rs m12,0328,028 149.9%   
Net working cap to sales %53.936.0 149.8%  
Current ratio x3.21.3 247.1%  
Inventory Days Days661 10.1%  
Debtors Days Days273 2.9%  
Net fixed assets Rs m3,5417,118 49.8%   
Share capital Rs m21361 346.9%   
"Free" reserves Rs m27,5448,427 326.9%   
Net worth Rs m27,7568,488 327.0%   
Long term debt Rs m0341 0.0%   
Total assets Rs m42,07217,523 240.1%  
Interest coverage x57.59.0 638.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.20.4 309.9%   
Return on assets %19.471.8 27.1%  
Return on equity %28.8127.0 22.7%  
Return on capital %39.6184.6 21.4%  
Exports to sales %0.718.2 3.9%   
Imports to sales %10.222.4 45.6%   
Exports (fob) Rs m3501,205 29.1%   
Imports (cif) Rs m5,0341,484 339.1%   
Fx inflow Rs m4151,236 33.5%   
Fx outflow Rs m5,1171,735 294.9%   
Net fx Rs m-4,702-499 941.7%   
CASH FLOW
From Operations Rs m9,477-1,084 -873.9%  
From Investments Rs m-3,95812,826 -30.9%  
From Financial Activity Rs m-6,374-11,759 54.2%  
Net Cashflow Rs m-856-17 4,948.5%  

Share Holding

Indian Promoters % 0.0 73.6 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 8.1 0.4 1,872.1%  
FIIs % 0.2 0.1 142.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 26.4 94.7%  
Shareholders   83,526 49,078 170.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    


More on Abbott India vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Abbott India vs Panacea Biotech Share Price Performance

Period Abbott India Panacea Biotech S&P BSE HEALTHCARE
1-Day -1.69% 2.31% -0.10%
1-Month 3.01% -2.48% -1.99%
1-Year 6.11% -37.30% -5.62%
3-Year CAGR 16.96% 4.48% 20.96%
5-Year CAGR 29.54% -11.81% 11.47%

* Compound Annual Growth Rate

Here are more details on the Abbott India share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of Abbott India hold a 75.0% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Abbott India and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, Abbott India paid a dividend of Rs 275.0 per share. This amounted to a Dividend Payout ratio of 73.2%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Abbott India, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.